Hasegawa T - Search Results

1

Regulation of the tubulin polymerization-promoting protein by Ca²⁺/S100 proteins.

Doi S, Fujioka N, Ohtsuka S, Kondo R, Yamamoto M, Denda M, Magari M, Kanayama N, Hatano N, Morishita R, Hasegawa T, Tokumitsu H. Doi S, et al. Among authors: hasegawa t. Cell Calcium. 2021 Jun;96:102404. doi: 10.1016/j.ceca.2021.102404. Epub 2021 Mar 27. Cell Calcium. 2021. PMID: 33831707 Free article.

2

Parkinson's disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking.

Yoshida S, Hasegawa T, Suzuki M, Sugeno N, Kobayashi J, Ueyama M, Fukuda M, Ido-Fujibayashi A, Sekiguchi K, Ezura M, Kikuchi A, Baba T, Takeda A, Mochizuki H, Nagai Y, Aoki M. Yoshida S, et al. Among authors: hasegawa t. Hum Mol Genet. 2018 Mar 1;27(5):823-836. doi: 10.1093/hmg/ddy003. Hum Mol Genet. 2018. PMID: 29309590

3

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, Kikuchi A, Itoyama Y, Takeda A. Hasegawa T, et al. Neurochem Int. 2010 Dec;57(8):857-66. doi: 10.1016/j.neuint.2010.09.002. Epub 2010 Sep 16. Neurochem Int. 2010. PMID: 20849899

4

[Emerging Disease-modifying Strategies Targeting α-synuclein in Parkinson's Disease].

Hasegawa T, Kobayashi J, Ishiyama S. Hasegawa T, et al. Brain Nerve. 2020 Feb;72(2):143-150. doi: 10.11477/mf.1416201494. Brain Nerve. 2020. PMID: 32036340 Review. Japanese.

5

Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.

Matsuzaki M, Hasegawa T, Takeda A, Kikuchi A, Furukawa K, Kato Y, Itoyama Y. Matsuzaki M, et al. Among authors: hasegawa t. Brain Res. 2004 Apr 9;1004(1-2):83-90. doi: 10.1016/j.brainres.2004.01.017. Brain Res. 2004. PMID: 15033422

6

Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.

Hasegawa T, Matsuzaki M, Takeda A, Kikuchi A, Akita H, Perry G, Smith MA, Itoyama Y. Hasegawa T, et al. Brain Res. 2004 Jul 2;1013(1):51-9. doi: 10.1016/j.brainres.2004.04.018. Brain Res. 2004. PMID: 15196967

7

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification.

Sugeno N, Hasegawa T. Sugeno N, et al. Among authors: hasegawa t. Int J Mol Sci. 2023 Apr 2;24(7):6645. doi: 10.3390/ijms24076645. Int J Mol Sci. 2023. PMID: 37047616 Free PMC article. Review.

8

[Targeting Transcellular Transport of α-Synuclein for Developing Disease-Modifying Therapies for Synucleinopathy].

Hasegawa T. Hasegawa T. Brain Nerve. 2018 May;70(5):551-556. doi: 10.11477/mf.1416201037. Brain Nerve. 2018. PMID: 29760292 Japanese.

9

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.

Yoshida S, Hasegawa T. Yoshida S, et al. Among authors: hasegawa t. Neurochem Int. 2022 May;155:105307. doi: 10.1016/j.neuint.2022.105307. Epub 2022 Feb 15. Neurochem Int. 2022. PMID: 35181393 Review.

10

Sortilin acts as an endocytic receptor for α-synuclein fibril.

Ishiyama S, Hasegawa T, Sugeno N, Kobayashi J, Yoshida S, Miki Y, Wakabayashi K, Fukuda M, Kawata Y, Nakamura T, Sato K, Ezura M, Kikuchi A, Takeda A, Aoki M. Ishiyama S, et al. Among authors: hasegawa t. FASEB J. 2023 Jul;37(7):e23017. doi: 10.1096/fj.202201605RR. FASEB J. 2023. PMID: 37272890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,313 results

Search Page